Latest News and Press Releases
Want to stay updated on the latest news?
-
NANTES, France, le 3 juin 2026, 20h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) (la « Société »), annonce la tenue de son Assemblée Générale Mixte le 24 juin 2026 à 10h00...
-
MUTSAMUDU, Comoros, June 03, 2026 (GLOBE NEWSWIRE) -- MEXC, a leading 0-fee cross-asset trading platform, today announced the official launch of 'RealStocks.' This innovative equity product is now...
-
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document
-
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025 Les résultats financiers consolidés...
-
BANGKOK, June 03, 2026 (GLOBE NEWSWIRE) -- Starcoin Foundation announced its headline presence at Southeast Asia Blockchain Week (SEABW) 2026, presenting the Football Community Cup and serving as an...
-
Aliro is the open credential standard reshaping physical access control. Learn what enterprise security leaders must act on before 2027.
-
San Ramon, CA, June 03, 2026 (GLOBE NEWSWIRE) -- Flosum, the leading end-to-end DevOps, data management, and data protection platform for Salesforce, today announced a comprehensive update to Flosum...
-
NULISA™ DBS 萃取試劑盒可從主流的第三方遙距採集樣本裝置收集的乾燥血點與乾燥血漿微量樣本中萃取蛋白質 此工作流程將 NULISA 的應用範圍擴展至縱向研究、去中心化研究,以及大規模族群研究 加州佛利蒙, June 04, 2026 (GLOBE NEWSWIRE) -- 致力於實現疾病最早期偵測的精準蛋白質體學頂尖機構 Alamar Biosciences, Inc....
-
NULISA™ DBS提取试剂盒可从主流第三方远程采样设备采集的干血斑、干血浆斑微量样本中提取蛋白质 该流程将NULISA技术推广至纵向研究、去中心化研究和大规模人群研究 加利福尼亚州弗里蒙特, June 04, 2026 (GLOBE NEWSWIRE) -- 致力于尽早发现疾病的精准蛋白质组学领先企业Alamar Biosciences, Inc. (Nasdaq: ALMR)...
-
NEWPORT NEWS, Va., June 03, 2026 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Newport News Shipbuilding division is welcoming more than 50 graduating high school seniors to shipbuilding careers through an...